ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
ProKidney Corp (Nasdaq: PROK), a late clinical-stage biotech company developing cell therapy for chronic kidney disease (CKD), has announced its participation in two major healthcare conferences this December. The company will join the Evercore HealthCONx Conference on December 3, 2024, featuring a fireside chat at 8:45am ET with a live webcast available. Additionally, ProKidney will participate in the Citi Global Healthcare Conference on December 4, 2024, conducting one-on-one meetings.
The Evercore fireside chat webcast will be accessible through ProKidney's website investor relations section. Interested investors can arrange meetings through their Evercore and Citi representatives.
ProKidney Corp (Nasdaq: PROK), una società biotecnologica in fase clinica avanzata che sviluppa terapie cellulari per la malattia renale cronica (CKD), ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo dicembre. L'azienda parteciperà alla Evercore HealthCONx Conference il 3 dicembre 2024, con un incontro informale previsto per le 8:45 ET, disponibile in diretta streaming. Inoltre, ProKidney parteciperà al Citi Global Healthcare Conference il 4 dicembre 2024, conducendo incontri individuali.
Il webcast dell'incontro informale di Evercore sarà accessibile attraverso la sezione relazioni con gli investitori del sito web di ProKidney. Gli investitori interessati possono organizzare incontri attraverso i loro rappresentanti di Evercore e Citi.
ProKidney Corp (Nasdaq: PROK), una empresa biotecnológica en etapa clínica avanzada que desarrolla terapia celular para la enfermedad renal crónica (CKD), ha anunciado su participación en dos importantes conferencias de salud este diciembre. La empresa se unirá a la Evercore HealthCONx Conference el 3 de diciembre de 2024, con un chat informal a las 8:45 a.m. ET, disponible en transmisión en vivo. Además, ProKidney participará en la Citi Global Healthcare Conference el 4 de diciembre de 2024, llevando a cabo reuniones uno a uno.
El webcast del chat informal de Evercore será accesible a través de la sección de relaciones con inversores del sitio web de ProKidney. Los inversores interesados pueden organizar reuniones a través de sus representantes de Evercore y Citi.
ProKidney Corp (Nasdaq: PROK)는 만성 신장 질환(CKD)을 위한 세포 치료를 개발하는 임상 후기에 있는 생명공학 회사로, 이번 12월에 두 개의 주요 의료 회의에 참여한다고 발표했습니다. 회사는 2024년 12월 3일에 열리는 Evercore HealthCONx Conference에 참석하며, 오전 8시 45분 ET에 화상 채팅이 예정되어 있으며, 라이브 방송도 제공됩니다. 또한 ProKidney는 2024년 12월 4일에 열리는 Citi Global Healthcare Conference에도 참여하여 일대일 회의를 진행할 예정입니다.
Evercore의 화상 채팅 방송은 ProKidney 웹사이트의 투자자 관계 섹션을 통해 접근할 수 있습니다. 관심 있는 투자자는 Evercore 및 Citi 대표를 통해 회의 일정을 조정할 수 있습니다.
ProKidney Corp (Nasdaq: PROK), une entreprise biopharmaceutique en phase clinique avancée développant des thérapies cellulaires pour la maladie rénale chronique (CKD), a annoncé sa participation à deux grandes conférences sur la santé en décembre. L'entreprise assistera à la Evercore HealthCONx Conference le 3 décembre 2024, avec un entretien informel prévu à 8h45 ET, disponible en direct. De plus, ProKidney participera à la Citi Global Healthcare Conference le 4 décembre 2024, en réalisant des réunions individuelles.
Le webcast de l'entretien informel d'Evercore sera accessible via la section des relations investisseurs du site Web de ProKidney. Les investisseurs intéressés peuvent organiser des réunions par l'intermédiaire de leurs représentants d'Evercore et de Citi.
ProKidney Corp (Nasdaq: PROK), ein biopharmazeutisches Unternehmen in der späten klinischen Phase, das Zelltherapien für chronische Nierenerkrankungen (CKD) entwickelt, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im Dezember angekündigt. Das Unternehmen wird an der Evercore HealthCONx Conference am 3. Dezember 2024 teilnehmen und ein informelles Gespräch um 8:45 Uhr ET führen, das live gestreamt wird. Darüber hinaus wird ProKidney am Citi Global Healthcare Conference am 4. Dezember 2024 teilnehmen und Einzelgespräche führen.
Das Webcast des informellen Gesprächs von Evercore wird über den Bereich Investor Relations auf der Website von ProKidney zugänglich sein. Interessierte Investoren können Meetings über ihre Vertreter von Evercore und Citi organisieren.
- None.
- None.
WINSTON-SALEM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in December:
| Evercore HealthCONx Conference | |
| Date: | December 3, 2024 |
| Time: | 8:45am ET |
| Format: | Fireside Chat |
| Webcast: | Link |
| Citi Global Healthcare Conference | |
| Date: | December 4, 2024 |
| Format: | One-on-one meetings |
The live webcast for the Evercore fireside chat will be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Investors interested in one-on-one meetings should contact their Evercore and/or Citi representatives.
About ProKidney Corp.
ProKidney, a pioneer in the treatment of chronic kidney disease through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy being evaluated in Phase 2 and Phase 3 studies for its potential to preserve kidney function in diabetic patients at high risk of kidney failure. Rilparencel has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. For more information, please visit www.prokidney.com.
Investor Contacts:
ProKidney
Ethan Holdaway
Ethan.Holdaway@prokidney.com
LifeSci Advisors, LLC
Daniel Ferry
Daniel@lifesciadvisors.com
FAQ
When is ProKidney (PROK) presenting at the Evercore HealthCONx Conference 2024?
What conferences is ProKidney (PROK) attending in December 2024?
How can investors access ProKidney's (PROK) Evercore HealthCONx Conference presentation?
What is the format of ProKidney's (PROK) participation at the Citi Global Healthcare Conference?
